Your Trusted Partner for Small Molecule Drug Development

The use of small molecules for the treatment of psychiatric disorders such as schizophrenia, mood disorders, anxiety and autism is becoming a hot topic. However, developing new drugs is a complex and challenging process. As a leader in high-quality products and services for the chemical and pharmaceutical industries, Ace Therapeutics offers everything you need to optimize the development of therapeutic small molecules and shorten time to market.

Advancing Psychiatric Research

Ace Therapeutics is passionate about advancing psychiatry through superior products, and we are committed to providing pure chemical reagents designed for scientific research purposes. It is important to emphasize that at this time we do not offer GMP, DMF, or ISO certified products, nor do we offer controlled substances. It is also worth noting that we are not an FDA-approved manufacturer, which means that our products cannot be used in clinical trials or for the treatment of disease. Our primary focus is to support and promote scientific research by providing high quality reagents for laboratory studies.

Flexibility to Meet Your Small Molecule Discovery Program Needs

Ace Therapeutics is building the world's most comprehensive inventory of drugs for small molecule research. We distribute high quality reagents to support research scientists in academic, biotech, biomedical and pharmaceutical organizations. With our experience and expertise, your small molecule discovery and non-clinical goals can be achieved in the shortest possible time. Whether you need a single study or a complete IND program, we will work with you to design and execute it with confidence.

Please click on the links below to find products related to your area of interest.